The Orphan Drug Act of 1983 is a law passed in the United States to facilitate development of orphan drugs, drugs for rare diseases such as Huntington’s Disease, myoclonus, ALS, Tourette syndrome and muscular dystrophy which affect small numbers of individuals living in the United States.

<< Back to Glossary Index